Abstract
We treated a 37 years old female who has essential thrombocytosis and developed NSTEMI with GPIIb IIIa inhibitors in addition to standard treatment with dual anti platelet therapy, low molecular heparin, beta blocker and ACE inhibitor and had good recovery of left ventricular function without any bleeding complication. Since these patients have both bleeding and thrombotic complications, it is prudent to carefully follow these patients during treatment and on follow up. (Rawal Med J 2008;33:262-263).
Key words: : Essential thrombocytosis, NSTEMI, EF, Von Willibands Factor, coronary angiography, angiotensin converting enzyme inhibitors.
